Company Filing History:
Years Active: 2025
Title: Jiangyu Li: Innovator in AAV Capsid Variants
Introduction
Jiangyu Li is a prominent inventor based in Watertown, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of adeno-associated virus (AAV) capsid variants. With a total of 2 patents, his work is paving the way for advancements in gene therapy and related applications.
Latest Patents
Jiangyu Li's latest patents focus on AAV capsid variants and their uses. The disclosures relate to compositions and methods for the preparation, use, and/or formulation of adeno-associated virus capsid protein variants. These innovations are crucial for enhancing the efficacy and safety of gene delivery systems.
Career Highlights
Currently, Jiangyu Li is associated with Voyager Therapeutics, Inc., where he continues to push the boundaries of research in gene therapy. His expertise in AAV technology has positioned him as a key player in the biotechnology sector.
Collaborations
Jiangyu Li collaborates with notable colleagues such as Mathieu E Nonnenmacher and Tyler Christopher Moyer. Their combined efforts contribute to the advancement of innovative solutions in the field.
Conclusion
Jiangyu Li's work in AAV capsid variants exemplifies the impact of innovation in biotechnology. His contributions are vital for the future of gene therapy and its applications.